Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01826942 · ClinicalTrials.gov registry record · NA
Scar Prevention Using Fractional Carbon Dioxide Laser Treatment
A NA study, sponsored by Lumenis Be.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01826942: Clinical Trial NA study, sponsored by Lumenis Be.
NCT01826942 is a NA study that was terminated before completion, run by Lumenis Be. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01826942, a NA study, was terminated before completion, sponsored by Lumenis Be.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
In this study the investigators intend to determine the impact of fractional CO2 laser treatment on the edges of a fresh wound during surgical area closure on thin skin (e.g. face, hands, arms, thorax, etc.) and on thick skin (abdominoplasty procedure) on scar formation. The investigators will also evaluate the effect of shallow fractional laser treatment versus deep parameters settings. If effective treatments could be performed at time of surgery, this would result in both time and cost saving to the patient and to the healthcare system and will improve patient's self-image post surgeries.
Interventions
- DEVICE Lumenis UltraPulse single fractional CO2 laser treatment thin skin
- DEVICE Single fractional CO2 treatment at surgical area closure procedure on thick skin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-03 |
| Phase | NA |
Why NCT01826942 stopped before completion
NCT01826942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Lumenis UltraPulse single fractional CO2 laser treatment thin skin is the first listed.
NCT01826942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01826942 about?
NCT01826942 is a clinical study titled "Scar Prevention Using Fractional Carbon Dioxide Laser Treatment". In this study the investigators intend to determine the impact of fractional CO2 laser treatment on the edges of a fresh wound during surgical area closure on thin skin (e.g. face, hands, arms, thorax, etc.) and on thick skin (abdominoplasty procedure) on scar formation. The investigators will also ...
What is the current status of trial NCT01826942?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2013-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01826942?
The interventions under investigation include: Lumenis UltraPulse single fractional CO2 laser treatment thin skin (DEVICE), Single fractional CO2 treatment at surgical area closure procedure on thick skin (DEVICE).
Who is sponsoring clinical trial NCT01826942?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01826942's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia